Gut health boost could slow kidney disease, new trial hopes
NCT ID NCT07182942
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a drug called Xiqing, which absorbs waste in the gut, works better when combined with probiotics in people with chronic kidney disease (CKD). The trial will enroll 120 adults with moderate to advanced CKD who are not on dialysis. Researchers will track kidney function and heart health to see if the combination helps slow disease progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Xiqing (a coated aldehyde oxystarch capsule that absorbs waste) and probiotics (Lactobacillus casei Zhang)
What this could lead to
If successful, this could show that combining Xiqing with probiotics better slows kidney disease progression and reduces complications.
What could go wrong
This is a small, early-phase trial with 120 participants, so results may not apply to all CKD patients. Risks include side effects from the drugs or no added benefit from probiotics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••